If you have had a COPD exacerbation in the last 12 months that required medical attention, you may qualify to participate in a clinical research study. We are testing new investigational therapies to find out if they can reduce airway inflammation and improve COPD symptoms.
This clinical research study is investigating whether a new treatment may help cut down on the number and severity of COPD flare-ups. The goal is to better understand how to support people living with COPD in breathing more easily and enjoying more stability in daily life.
The purpose of this study is to evaluate how the body responds to the combination of ensifentrine and glycopyrrolate, both together and individually. The study medication is administered as an inhaled treatment and may help open the airways and reduce inflammation in the lungs.
Participating in a clinical trial gives patients access to medications of the future for the diseases of today.
By meeting with our research team for a prescreening appointment, we can discuss which research programs you may be eligible for. These programs are at no cost to patients and do not involve their insurance. Some programs may reimburse patients for their participation.
Pharmaceutical Sponsor?
We have worked with sponsors such as AstraZeneca, Pfizer, Glaxo Smith Kline, Rebiotix, Novo Nordisk, and Janssen.
If you are a sponsor who would like to learn more about our site:
.png)
